表紙
市場調查報告書

全球臨床試驗用品市場:2018年∼2022年

Global Clinical Trial Supplies Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 609194
出版日期 內容資訊 英文 129 Pages
訂單完成後即時交付
價格
全球臨床試驗用品市場:2018年∼2022年 Global Clinical Trial Supplies Market 2018-2022
出版日期: 2018年02月28日內容資訊: 英文 129 Pages
簡介

Technavio的市場調查分析師預測,全球臨床試驗用品市場至2022年將以超越8%的年複合成長率成長。

本報告提供全球臨床試驗用品市場相關調查,市場概要,各終端用戶、地區的市場趨勢,市場規模的變化與預測,成長促進因素及課題分析,競爭情形,主要企業簡介等彙整。

本報告處理的項目

  • 2022年的市場規模及成長率
  • 市場主要成長要素
  • 市場趨勢
  • 市場課題
  • 市場主要供應商
  • 供應商面臨的市場機會及威脅
  • 影響地區佔有率的趨勢係數
  • 波特的五力分析和其結果

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模的預測

第6章 波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
  • 市場情形

第7章 客戶形勢

第8章 臨床試驗用品市場:各終端用戶

  • 市場區隔:各終端用戶
  • 比較:各終端用戶
  • 醫療設備廠商
  • 生物製藥企業
  • 製藥企業
  • 市場機會:各終端用戶

第9章 地區形勢

  • 市場區隔:各地區
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區
  • 主要市場牽引國
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • CRO(醫藥品開發受託機關)的需求高漲
  • 製藥產業為中心的研究增加
  • e-臨床試驗的需求高漲

第13章 業者情勢

  • 概要
  • 創造性破壞狀況

第14章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Almac Group
  • DHL
  • PAREXEL International
  • Thermo Fisher Scientific
  • UPS
  • 其他有力供應商

第15章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR20632

This industry research report presents a comprehensive analysis of the clinical trial supplies market by end-user based on pharmaceutical industry, biologics industry, medical device industry. The report also provides an analysis of the market based on geographic regions such as the Americas, APAC, and EMEA.

Our market research analysts predict that this market will grow at a CAGR of more than 8% by 2022.

Key questions answered in the report include:

  • What will the market size and the growth rate be in 2022?
  • What are the key factors driving the global clinical trial supplies market?
  • What are the key market trends impacting the growth of the global clinical trial supplies market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global clinical trial supplies market?
  • What are the market opportunities and threats faced by the vendors in the global clinical trial supplies market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global clinical trial supplies market?

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Comparison by end-user
  • Medical device industry
  • Biologics industry
  • Pharmaceutical industry
  • Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Growing demand of CROs
  • Increase in studies focusing on pharmaceutical industry
  • Rising demand of e-clinical trials

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Almac Group
  • DHL
  • PAREXEL International
  • Thermo Fisher Scientific
  • UPS
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition - Inclusions and exclusions checklist
  • Exhibit 05: Validation techniques employed for market sizing 2017
  • Exhibit 06: Global - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 07: Global - Year-over-year growth 2018-2022 (%)
  • Exhibit 08: Five forces analysis 2017
  • Exhibit 09: Five forces analysis 2022
  • Exhibit 10: Bargaining power of buyers
  • Exhibit 11: Bargaining power of suppliers
  • Exhibit 12: Threat of new entrants
  • Exhibit 13: Threat of substitutes
  • Exhibit 14: Threat of rivalry
  • Exhibit 15: Market condition - Five forces 2017-2022
  • Exhibit 16: Customer landscape
  • Exhibit 17: End-user - Market share 2017-2022 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Medical device industry - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 20: Medical device industry - Year-over-year growth 2018-2022 (%)
  • Exhibit 21: Biologics industry - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 22: Biologics industry - Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Pharmaceutical industry - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Pharmaceutical industry - Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Global - Market share by geography 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Medical technology industry including IVD market in Europe in 2014
  • Exhibit 32: Growth of healthcare application in Europe in 2014 (% CAGR)
  • Exhibit 33: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 34: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Vendor overview
  • Exhibit 46: Almac Group - Business segments
  • Exhibit 47: Almac Group - Organizational developments
  • Exhibit 48: Almac Group - Geographic focus
  • Exhibit 49: Almac Group - Segment focus
  • Exhibit 50: Almac Group - Key offerings
  • Exhibit 51: Vendor overview
  • Exhibit 52: DHL - Business segments
  • Exhibit 53: DHL - Organizational developments
  • Exhibit 54: DHL - Geographic focus
  • Exhibit 55: DHL - Segment focus
  • Exhibit 56: DHL - Key offerings
  • Exhibit 57: Vendor overview
  • Exhibit 58: PAREXEL International - Business segments
  • Exhibit 59: PAREXEL International - Organizational developments
  • Exhibit 60: PAREXEL International - Geographic focus
  • Exhibit 61: PAREXEL International - Segment focus
  • Exhibit 62: PAREXEL International - Key offerings
  • Exhibit 63: Vendor overview

Note: Fisher Clinical service is a part of Biopharma Services Division of Thermo Fisher Scientific and operates as an independent company. In business segments, the business offerings of fisher clinical services are included.

  • Exhibit 64: Thermo Fisher Scientific - Business segments
  • Exhibit 65: Thermo Fisher Scientific - Organizational developments
  • Exhibit 66: Thermo Fisher Scientific - Geographic focus
  • Exhibit 67: Thermo Fisher Scientific - Segment focus
  • Exhibit 68: Thermo Fisher Scientific - Key offerings
  • Exhibit 69: Vendor overview
  • Exhibit 70: UPS - Business segments
  • Exhibit 71: UPS - Organizational developments
  • Exhibit 72: UPS - Geographic focus
  • Exhibit 73: UPS - Segment focus
  • Exhibit 74: UPS - Key offerings